The Michigan Retinal Degeneration Questionnaire: A Patient-Reported Outcome Instrument for Inherited Retinal Degenerations.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
02 2021
Historique:
received: 07 05 2020
revised: 13 08 2020
accepted: 20 08 2020
pubmed: 29 8 2020
medline: 17 3 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

To create a psychometrically validated patient-reported outcome measure for inherited retinal degenerations. Qualitative and quantitative patient-reported outcome (PROs) questionnaire development using item response theory validation. One hundred twenty-eight patients with a diagnosis of an inherited retinal degeneration at the Kellogg Eye Center (University of Michigan) were recruited and administered a 166-item questionnaire comprising 7 expert-defined domains. The questionnaire was re-administered 4-16 days later to a subset of 25 participants to assess test-retest variability. Graded response models were fit by Cai's Metropolis-Hastings Robbins-Monro algorithm using the R (version 3.6.3) package mirt. Model data were fit to assess questionnaire dimensionality, to estimate item information, and to score participants. Poorly functioning items were removed, and the model was refit to create the final questionnaire. The psychometrically validated PROs measure was reduced to a 59-item questionnaire measuring 7 unidimesnional domains: central vision, color vision, contrast sensitivity, scotopic function, photopic peripheral vision, mesopic peripheral vision, and photosensitivity. A total of 39 items were removed because of poor factor loading, low item information, poor person-ability differentiation, or high item-level interdependence. This novel questionnaire produces a reliable domain score for person ability that does not show significant test-retest variability across repeated administration. The final PRO questionnaire, known as the Michigan Retinal Degeneration Questionnaire, is psychometrically validated and available for use in the evaluation of patients with inherited retinal degenerations.

Identifiants

pubmed: 32858027
pii: S0002-9394(20)30461-X
doi: 10.1016/j.ajo.2020.08.032
pmc: PMC7907279
mid: NIHMS1624447
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-68

Subventions

Organisme : NEI NIH HHS
ID : K12 EY022299
Pays : United States
Organisme : NEI NIH HHS
ID : K23 EY026985
Pays : United States
Organisme : NEI NIH HHS
ID : K23 EY027848
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002242
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Ophthalmic Genet. 2020 Feb;41(1):1-6
pubmed: 32100594
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Ophthalmic Genet. 2020 Aug;41(4):315-324
pubmed: 32571121
Optom Vis Sci. 2019 Jan;96(1):27-34
pubmed: 30570601
Qual Life Res. 2007;16 Suppl 1:5-18
pubmed: 17375372
Invest Ophthalmol Vis Sci. 2015 Feb 09;56(2):918-31
pubmed: 25667399
Qual Life Res. 2020 Mar;29(3):775-781
pubmed: 31673921
Multivariate Behav Res. 2015;50(6):569-83
pubmed: 26717119
Ophthalmic Physiol Opt. 2019 Sep;39(5):378-391
pubmed: 31468574
Med Care. 2007 May;45(5 Suppl 1):S22-31
pubmed: 17443115
Lancet. 2014 Mar 29;383(9923):1129-37
pubmed: 24439297
BMC Ophthalmol. 2006 Jun 15;6:25
pubmed: 16774690
Am J Ophthalmol. 2019 Jan;197:65-73
pubmed: 30240725
Ophthalmology. 2016 Jul;123(7):1606-20
pubmed: 27102010
Optom Vis Sci. 2007 Aug;84(8):E690-705
pubmed: 17700325
PLoS One. 2018 Oct 18;13(10):e0206106
pubmed: 30335832
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
Am J Ophthalmol. 2018 Sep;193:130-142
pubmed: 29940166
Lancet. 2017 Aug 26;390(10097):849-860
pubmed: 28712537
Value Health. 2011 Dec;14(8):978-88
pubmed: 22152166
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37
pubmed: 17995471

Auteurs

Gabrielle D Lacy (GD)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Maria Fernanda Abalem (MF)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Ophthalmology and Otolaryngology, University of Sao Paulo Medical School, São Paulo, Brazil.

Chris A Andrews (CA)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Lilia T Popova (LT)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Erin P Santos (EP)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Gina Yu (G)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Hanan Y Rakine (HY)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Natasha Baig (N)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Joshua R Ehrlich (JR)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Abigail T Fahim (AT)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Kari H Branham (KH)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Joan A Stelmack (JA)

Department of Low Vision Service, Illinois Eye and Ear Infirmary, University of Illinois College of Medicine, Chicago, Illinois, USA.

Bonnielin K Swenor (BK)

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Gislin Dagnelie (G)

Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

David C Musch (DC)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.

K Thiran Jayasundera (KT)

Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA. Electronic address: thiran@umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH